Marc Feldmann Selected Research

Lipids

10/2015

Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Feldmann Research Topics

Disease

43	Rheumatoid Arthritis 01/2021 - 01/2002
25	Inflammation (Inflammations) 01/2022 - 03/2004
20	Necrosis 06/2022 - 01/2002
18	Arthritis (Polyarthritis) 01/2020 - 01/2003
14	Experimental Arthritis 10/2019 - 01/2003
10	Neoplasms (Cancer) 11/2023 - 01/2008
8	Pain (Aches) 05/2024 - 12/2007
8	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 08/2002
8	COVID-19 12/2022 - 01/2020
7	Atherosclerosis 11/2022 - 04/2002
5	Disease Progression 01/2022 - 08/2005
5	Fibrosis (Cirrhosis) 01/2022 - 12/2004
5	Infections 03/2015 - 02/2003
5	Crohn Disease (Crohn's Disease) 08/2007 - 01/2002
4	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 12/2002
4	Atherosclerotic Plaque (Atheroma) 10/2015 - 04/2004
4	Cognitive Dysfunction 03/2015 - 01/2010
4	Osteoarthritis 05/2010 - 01/2002
3	Dupuytren Contracture (Dupuytrens Contracture) 06/2022 - 07/2018
3	Hypoxia (Hypoxemia) 10/2020 - 08/2012
3	Wounds and Injuries (Trauma) 01/2018 - 09/2010
3	Neuroinflammatory Diseases 03/2015 - 01/2010
2	Bursitis (Adhesive Capsulitis) 05/2024 - 01/2022
2	Arthralgia (Joint Pain) 01/2020 - 05/2010
2	Hyperalgesia 08/2011 - 12/2007
2	Postoperative Cognitive Complications 11/2010 - 09/2010
2	Ankylosing Spondylitis 08/2007 - 05/2006
2	Glomerulonephritis 04/2007 - 05/2006
2	Pathologic Processes 12/2004 - 02/2003
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Insulin Resistance 01/2022
1	Obesity 09/2021

Drug/Important Bio-Agent (IBA)

43	CytokinesIBA 11/2023 - 01/2002
24	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 01/2002
11	LigandsIBA 09/2013 - 04/2002
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
9	NF-kappa B (NF-kB)IBA 12/2009 - 01/2002
8	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2022 - 03/2004
6	Interleukin-6 (Interleukin 6)IBA 10/2020 - 07/2003
6	Monoclonal AntibodiesIBA 06/2017 - 01/2002
6	Collagen Type II (Type II Collagen)IBA 09/2011 - 03/2003
5	Adalimumab (Humira)FDA Link 05/2024 - 11/2007
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
5	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 02/2003
4	Interleukin-8 (Interleukin 8)IBA 10/2020 - 07/2003
4	ChemokinesIBA 10/2015 - 03/2004
4	Infliximab (Remicade)FDA Link 01/2015 - 01/2002
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014 - 05/2006
4	Etanercept (Enbrel)FDA Link 09/2013 - 05/2006
4	Matrix Metalloproteinases (MMPs)IBA 12/2009 - 07/2003
3	CollagenIBA 01/2022 - 01/2003
3	AntigensIBA 09/2015 - 02/2003
3	LipopolysaccharidesIBA 03/2015 - 03/2004
3	Transcription Factors (Transcription Factor)IBA 08/2012 - 03/2007
3	Interleukin-1 (Interleukin 1)IBA 11/2010 - 08/2005
3	AntibodiesIBA 01/2010 - 08/2005
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2009 - 03/2004
2	EnzymesIBA 01/2023 - 03/2007
2	VaccinesIBA 01/2022 - 01/2022
2	InterleukinsIBA 10/2020 - 01/2010
2	Type II Tumor Necrosis Factor ReceptorsIBA 12/2019 - 10/2019
2	Apolipoproteins E (ApoE)IBA 10/2015 - 02/2011
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2015 - 12/2011
2	AngiopoietinsIBA 08/2012 - 10/2010
2	Messenger RNA (mRNA)IBA 03/2011 - 01/2008
2	ErbB Receptors (EGF Receptor)IBA 01/2011 - 10/2008
2	Interleukin-1beta (Interleukin 1 beta)IBA 09/2010 - 07/2003
2	Analgesics (Analgesic Drugs)IBA 05/2010 - 12/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2010 - 12/2009
2	p38 Mitogen-Activated Protein KinasesIBA 04/2007 - 12/2004
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2002 - 01/2002
1	Janus Kinase InhibitorsIBA 11/2023
1	deucravacitinibIBA 11/2023
1	estropipate (Ogen)FDA LinkGeneric 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	TrypsinIBA 01/2023
1	CholesterolIBA 11/2022
1	C-Type Lectins (C-Type Lectin)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	endotrophinIBA 01/2022
1	Calcium Gluconate (CBG)IBA 09/2021
1	AZD5153IBA 01/2021
1	InterferonsIBA 01/2020
1	Interferon Type IIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Interleukin-33IBA 12/2019
1	Tumor Necrosis Factor InhibitorsIBA 07/2018

Therapy/Procedure

33	Therapeutics 11/2023 - 01/2002
2	Intra-Articular Injections 05/2024 - 01/2022
2	Injections 06/2022 - 01/2015
2	Immunotherapy 01/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2018 - 11/2010
2	Orthopedic Procedures 03/2015 - 09/2010
2	Biological Therapy 01/2008 - 11/2007
1	Radiotherapy 01/2023
1	Adjuvant Chemotherapy 01/2023
1	Pain Management 01/2022
1	Traction 01/2020